Furthermore, GIPR antagonism in combination with GLP-1R agonism synergistically reduced BW in DIO mice and obese cynomolgus monkeys33, suggesting the potential for a GIPR/GLP-1R bispecific molecule for improving the efficacy of obesity treatment. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.